Artigliano, Italy

Riccardo Bernardi

This inventor holds 1 USPTO granted patent. Top assignee: Mediolanum Farmaceutici S.r.l. Consiglio Nazionale Delle Ricerch. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Riccardo Bernardi. Retrieved from https://idiyas.com/inventor/riccardo-bernardi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Riccardo Bernardi: Innovator in Pharmaceutical Chemistry

Introduction

Riccardo Bernardi is a notable inventor based in Artigliano, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of organic salts of physostigmine derivatives. His work focuses on enhancing the efficacy of treatments aimed at inhibiting acetylcholinesterase.

Latest Patents

Bernardi holds a patent for "Organic salts of physostigmine derivatives." This patent describes organic salts characterized by a general formula where R represents a linear or branched C2-C12 alkyl, a cycloalkyl, or an aryl. The anion, X-, is derived from an organic acid. The patent outlines the process for preparing these compounds and their pharmaceutical applications.

Career Highlights

Riccardo Bernardi is associated with Mediolanum Farmaceutici S.r.l. and the Consiglio Nazionale Delle Ricerche. His work at these institutions has allowed him to explore innovative solutions in drug development and contribute to advancements in medical science.

Collaborations

Throughout his career, Bernardi has collaborated with esteemed colleagues such as Carlo Meroni and Stefano Maiorana. These partnerships have fostered a collaborative environment that enhances research and innovation in the pharmaceutical sector.

Conclusion

Riccardo Bernardi's contributions to pharmaceutical chemistry, particularly through his patent on physostigmine derivatives, highlight his role as an innovator in the field. His work continues to influence the development of effective treatments for various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…